Cosmetic ingredient or research compound? How to read GHK-Cu listings

TL;DR

• GHK-Cu is a copper-bound three-amino-acid complex, but that scientific name alone does not identify a finished product, its route, or its evidence.¹
• Philippine FDA-hosted ASEAN guidance reads a cosmetic through its target site, main function, claims, presentation, product form, and way of use.²
• A cosmetic ingredient list usually follows weight order, but ingredients below one percent may be rearranged, so line position does not reveal an exact percentage.³
• Human topical, excised-skin laboratory, and US compounding records answer different questions; none can automatically validate a separate catalog listing that shares the GHK-Cu name.⁴

For Filipino readers scanning a blue serum box, a marketplace page, or a research listing, “GHK-Cu” may look like one stable category. The name alone gives too little information.⁴ It can appear beside a cosmetic ingredient line or in a different research context.⁴ Start with the route, product form, full presentation, and evidence for that exact item.²

Decode the name, then pause

GHK-Cu expands to glycyl-L-histidyl-L-lysine bound to copper.¹ The complex is built from a three-amino-acid peptide.¹ “GHK” names the glycine-histidine-lysine sequence, while “Cu” signals copper.¹ That translation is useful, but it is only an identity clue.⁴

A listing still needs a product form, intended site, route, responsible party, and complete claims.² Those details help define its category.² A familiar compound name cannot reveal the finished formula or exact concentration.⁴ It also cannot show quality controls or evidence for that item.⁴ Think of the name as the title on a folder, not everything inside it.⁴ The first task is to classify the listing before judging the ingredient.²

GHK-Cu is named here only as the neutral catalog reference below.⁴

What a Philippine cosmetic label should show

Philippine FDA hosts the ASEAN cosmetic labeling requirements used for this label check.⁵ Expected details include the cosmetic name and function.⁵ Use instructions also belong when the presentation does not make them clear.⁵ The framework calls for a full ingredient list and country of manufacture.⁵ It also names the local company or person responsible for the product.⁵

Contents, a batch number, needed date details, and precautions also belong in the framework.⁵ On a small container, some details may move to allowed support material.⁵ The product name and batch number must remain on the immediate pack.⁵ Together, these details link the item to its identity and batch.⁵ They also name a responsible local party.⁵ A page that repeats only GHK-Cu gives far less context than a full cosmetic presentation.⁴

Read ingredient order without inventing a percentage

Cosmetic ingredients usually run from greater to smaller weight when they are added.³ The pattern has an important break.³ Ingredients below one percent may appear in any order after those above one percent.³ Colorants and fragrance entries have their own rules.³

A low position can suggest that an ingredient sits later in the formula.³ It cannot supply an exact concentration.³ Two formulas can place the same named ingredient differently without becoming equal products.⁴ The ASEAN document points to several standard naming references.⁶ They include the International Cosmetic Ingredient Dictionary and named drug or chemical references.⁶ Standard names help readers spot ingredients across labels.⁶ They do not prove that two formulas share strength, stability, purity, or performance.⁴

Route and presentation decide the lane

The ASEAN claim guide uses five parts to decide a product category.² They are composition, target site, main function, presentation, and effect on the body.² Cosmetics are framed for named external body areas, teeth, or the mouth lining.⁷ Their main functions include changing appearance or keeping those sites in good condition.⁷ A product intended for ingestion or an injectable route cannot be a cosmetic under that process.⁷

Presentation reaches beyond a front label.² The guide considers claims, graphics, inserts, ads, product form, and way of use.² It also considers the audience being addressed.² Route can therefore change the category.⁷ A serum ingredient line and a page about a non-cosmetic route are not interchangeable.⁴ A shared GHK-Cu name does not erase that difference.⁴

The small human topical study was mixed

One randomized study examined topical skin-care regimens after facial carbon-dioxide laser resurfacing.⁸ Thirteen people completed the 12-week comparison.⁸ The regimens did or did not contain GHK-Cu.⁸ This small, procedure-specific group was not a broad test of everyday cosmetic use.⁸

Computer analysis and blinded reviewers found no clear between-group edge for earlier redness relief.⁹ They also found no objective between-group gain in wrinkles or overall skin quality.⁹ The participant survey pointed another way.⁹ Satisfaction with overall skin quality was higher in the GHK-Cu group.⁹ Both results belong in the summary.⁹ An objective check and a personal rating are different endpoints.⁹ The study result does not transfer to every formula or listing with the same name.⁴

Skin passage studies test the barrier

A 48-hour lab study placed a water-based GHK-Cu preparation on separated human skin layers.¹⁰ The samples sat in diffusion cells.¹⁰ Measured copper passage and retention varied by skin layer.¹⁰ The layers included stratum corneum, epidermis, and dermatomed skin.¹⁰ This design examined transport through prepared tissue.¹⁰ It did not measure appearance or comfort in living people.¹⁰

Another ex-vivo test compared intact human skin with microneedle-treated skin.¹¹ Over nine hours, peptide and copper passed through the treated samples.¹¹ Almost none passed through intact samples under those conditions.¹¹ The delivery method and skin barrier must stay with the result.¹¹ The test did not establish a cosmetic outcome or personal safety result.¹¹ It also did not assess a separate finished product.¹¹

Glutathione is named here only as the neutral catalog reference below.

Use two records, not one shortcut

For a Philippine cosmetic, the FDA Verification Portal includes a notified-cosmetics list.¹² It is separate from registered health products and approved clinical trials.¹² Search the category that matches the product presentation.¹² Use the exact product and responsible-company details.¹² A paper cannot replace the local record of a finished cosmetic.¹²

Research-compound context needs a different check.² In the United States, FDA flags compounded injectable GHK-Cu for possible immune-response risk.¹³ Its reasons include peptide clumping and related impurities.¹³ The agency says human safety information for this issue is limited.¹³ That record is specific to the United States and to the route.¹³ It is not a Philippine status decision or a review of a topical cosmetic.¹³ Keep jurisdiction, route, formula, and evidence attached to each statement.⁴

Bottom line

GHK-Cu is a compound name, not a complete product biography.⁴ On a cosmetic, read the function, instructions, full ingredient line, responsible local party, batch details, precautions, and the rest of the presentation.⁵ Do not turn ingredient order into an invented percentage, especially below the one-percent threshold.³ For research claims, name the model and endpoint: a small topical trial, an excised-skin transport test, and an injectable compounding notice do not answer the same question.⁴ In the Philippines, check the FDA portal category that matches the exact finished item.¹² The reliable reading keeps the name, route, product form, jurisdiction, and source in one frame.⁴

This article is educational research context, not medical advice. Catalog links are neutral references and do not imply a treatment or human-use recommendation.

Frequently asked questions

Are GHK-Cu and copper tripeptide the same name?

GHK-Cu is the shortened research name for glycyl-L-histidyl-L-lysine complexed with copper.¹ A cosmetic label may use standardized ingredient nomenclature rather than the abbreviation.⁶ Name recognition helps with identification, but it does not establish the formula, concentration, route, quality, or evidence of a finished item.⁴

Can ingredient order reveal how much GHK-Cu is present?

Not exactly. Ingredients generally descend by weight when added, but those below one percent may appear in any order after ingredients above that threshold.³ The line therefore offers ordering context, not a precise percentage.³ Exact composition belongs to fuller finished-product documentation rather than a consumer ingredient line.¹⁴

What makes a GHK-Cu listing cosmetic?

The name alone does not do it.⁴ ASEAN guidance considers composition, target site, main cosmetic function, claims, presentation, product form, and way of use.² Cosmetic context centers on named external sites, teeth, or oral mucosa; a product for an injectable route sits outside that cosmetic decision lane.⁷

What did the topical human study find?

In 13 participants after facial laser resurfacing, objective and blinded measures found no significant between-group benefit for redness, wrinkles, or overall skin quality.⁹ The GHK-Cu group reported higher satisfaction with overall skin quality.⁹ Those differing endpoints should stay separate, and the procedure-specific study should not represent every formulation.⁸

Does passage through excised skin prove a visible result?

No. Diffusion-cell work measured copper movement and retention across prepared human skin layers.¹⁰ The microneedle experiment measured passage through treated ex-vivo skin compared with intact samples.¹¹ Neither design measured a participant’s appearance, experience, or finished-product result, so transport findings should remain laboratory context.¹¹

How can Filipino readers check a cosmetic record?

The Philippine FDA advisory says its Verification Portal includes a list of notified cosmetic products alongside separate regulatory lists.¹² Search the cosmetic category with the exact product and responsible-company details rather than relying on the ingredient name alone.¹² A matching name in a paper cannot replace finished-product identification.⁴

Sources

Footnotes

1. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. The PubMed-indexed randomized topical study states the expanded chemical name and abbreviation. A chemical name does not identify a finished product, route, concentration, quality, or intended use. ↩ ↩² ↩³ ↩⁴ ↩⁵

2. ASEAN Cosmetic Claim Guideline. Philippine FDA-hosted ASEAN cosmetic claim guideline. No single keyword or ingredient name settles the category by itself. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹²

3. ASEAN Cosmetic Labeling Requirements. Ingredient-order rule in the Philippine FDA-hosted ASEAN labeling requirements. List position does not disclose an exact percentage, and colorants and fragrance declarations have additional rules. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰

4. ASEAN Cosmetic Labeling Requirements; ASEAN Cosmetic Claim Guideline; ASEAN Cosmetic Directive Guidelines for Product Information File. Synthesis of Philippine FDA-hosted labeling, category, and finished-product information guidance. The conclusion is a reading principle derived from the distinct information required across those official documents, not a judgment about any named listing. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵ ↩¹⁶ ↩¹⁷ ↩¹⁸ ↩¹⁹ ↩²⁰ ↩²¹

5. ASEAN Cosmetic Labeling Requirements. Philippine FDA-hosted ASEAN cosmetic labeling requirements. Small packages may place some details on permitted supporting materials, and the rules contain specific exceptions. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹

6. ASEAN Cosmetic Labeling Requirements. Appendix A of the Philippine FDA-hosted labeling requirements. A standardized ingredient name is a naming convention, not proof of a finished product's composition or performance. ↩ ↩² ↩³ ↩⁴

7. ASEAN Cosmetic Claim Guideline. Philippine FDA-hosted ASEAN decision process for cosmetic products and claims. This is category guidance and does not determine the status of every individual listing without its complete presentation. ↩ ↩² ↩³ ↩⁴ ↩⁵

8. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Randomized human study after circumoral carbon-dioxide laser resurfacing. The small, procedure-specific study does not represent routine use on uninjured skin or other formulations. ↩ ↩² ↩³ ↩⁴ ↩⁵

9. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Results of the 13-completer randomized topical study. The objective and self-reported findings differed and should remain separate. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

10. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Flow-through diffusion-cell experiment using prepared human skin layers. This was an excised-tissue transport experiment, not a participant-level cosmetic or clinical outcome. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

11. Microneedle-mediated delivery of copper peptide through skin. Laboratory comparison of intact and microneedle-treated prepared human skin. The result concerns a delivery method in excised skin and cannot establish a benefit or safety outcome in people. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

12. FDA Advisory No. 2023-2238: Utilization of the Food and Drug Administration Verification Portal. Philippine FDA advisory describing the public Verification Portal. A category search should use the exact product and responsible-company details; one list does not substitute for another. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

13. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Current U.S. FDA compounding-risk record specific to injectable routes. This is not a Philippine regulatory determination and does not assess a named topical cosmetic. ↩ ↩² ↩³ ↩⁴ ↩⁵

14. ASEAN Cosmetic Directive Guidelines for Product Information File. Philippine FDA-hosted ASEAN Product Information File guideline. The consumer-facing ingredient line is not the same as the fuller file maintained for regulatory access. ↩